Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > XRAY PDT TRIAL IN GERMANY

<< Previous

Bullboard Posts

Next >>

Post by Tarbabyon Aug 14, 2024 12:43pm

609 Views

Post# 36178771

XRAY PDT TRIAL IN GERMANY

Www.clinicalkey.com is a website that shows this ongoing clinical trial.
At University of Meunster.
They are using 5ALA as the pdt compound but we know that Rutherrin is much more effective. This will prove the concept and pave the way for TLT.v to do the same once they find a jv to foot the cost.
Roger should approach Meunster to do it..

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec